HCA Healthcare Inc (HCA) SVP Sells $3,902,833.48 in Stock

HCA Healthcare Inc (NYSE:HCA) SVP Victor L. Campbell sold 28,084 shares of HCA Healthcare stock in a transaction on Monday, February 11th. The stock was sold at an average price of $138.97, for a total transaction of $3,902,833.48. Following the completion of the transaction, the senior vice president now directly owns 231,493 shares of the company’s stock, valued at approximately $32,170,582.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

HCA stock traded down $0.87 during mid-day trading on Monday, reaching $138.66. The company had a trading volume of 1,008,119 shares, compared to its average volume of 1,587,261. The stock has a market capitalization of $48.02 billion, a price-to-earnings ratio of 14.19, a PEG ratio of 1.16 and a beta of 0.80. HCA Healthcare Inc has a one year low of $93.03 and a one year high of $147.42.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 29th. The company reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.59 by $0.40. HCA Healthcare had a net margin of 8.11% and a negative return on equity of 91.25%. The business had revenue of $12.27 billion for the quarter, compared to analysts’ expectations of $12.10 billion. During the same period in the previous year, the business earned $2.12 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis. Analysts predict that HCA Healthcare Inc will post 10.02 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 1st will be paid a dividend of $0.40 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date of this dividend is Thursday, February 28th. HCA Healthcare’s payout ratio is currently 14.33%.

A number of research firms have commented on HCA. Oppenheimer lifted their price objective on shares of HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a report on Wednesday, January 30th. SunTrust Banks lifted their price objective on shares of HCA Healthcare to $175.00 and gave the stock a “buy” rating in a report on Wednesday, January 30th. Leerink Swann lifted their price objective on shares of HCA Healthcare from $160.00 to $175.00 and gave the stock an “outperform” rating in a report on Wednesday, January 30th. Stephens began coverage on shares of HCA Healthcare in a report on Monday, January 14th. They issued an “overweight” rating and a $143.00 price objective for the company. Finally, Deutsche Bank began coverage on shares of HCA Healthcare in a report on Thursday, January 3rd. They issued a “buy” rating and a $140.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and eighteen have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $148.43.

Large investors have recently added to or reduced their stakes in the stock. Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare during the fourth quarter worth about $25,000. Moody National Bank Trust Division acquired a new position in HCA Healthcare during the fourth quarter worth about $27,000. Doyle Wealth Management acquired a new position in HCA Healthcare during the fourth quarter worth about $31,000. Trust Co. of Vermont grew its holdings in HCA Healthcare by 165.3% during the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock worth $41,000 after acquiring an additional 205 shares during the period. Finally, Csenge Advisory Group acquired a new position in HCA Healthcare during the third quarter worth about $48,000. 72.85% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.themarketsdaily.com/2019/02/12/hca-healthcare-inc-hca-svp-sells-3902833-48-in-stock.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: What are defining characteristics of a correction?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.